Health Dictionary Find a Doctor

Fibromuscular dysplasia management guidelines

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Management Guidelines

2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS: Guidelines on the Management of Patients With Extracranial Carotid and Vertebral Artery Disease (DO NOT EDIT)[1]

Management of Patients With Fibromuscular Dysplasia of the Extracranial Carotid Arteries (DO NOT EDIT)[1]

Class III (No Benefit)
1. Revascularization is not recommended for patients with asymptomatic FMD (Fibro Muscular Dysplasia) of a carotid artery, regardless of the severity of stenosis. (Level of Evidence: C)
Class IIa
1. Annual noninvasive imaging of the carotid arteries is reasonable initially for patients with fibromuscular dysplasia (FMD) to detect changes in the extent or severity of disease, although the effect on outcomes is unclear. Studies may be repeated less frequently once stability has been confirmed. (Level of Evidence: C)
2. Administration of platelet-inhibitor medication can be beneficial in patients with FMD of the carotid arteries to prevent thromboembolism, but the optimum drug and dosing regimen have not been established. (Level of Evidence: C)
3. Carotid angioplasty with or without stenting is reasonable for patients with retinal or hemispheric cerebral ischemic symptoms related to FMD of the ipsilateral carotid artery, but comparative data addressing these methods of revascularization are not available. (Level of Evidence: C)

References

Template:WH Template:WS

© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH